North Star Investment Management’s Purple Biotech PPBT Stock Holding History
Bought
Maintained
Sold
Other funds holding PPBT
SP
North Star Investment Management's PPBT Position: Q4 2025 in Review
North Star Investment Management sold out of Purple Biotech (PPBT) in Q4 2025, closing a stake of 2 shares — an estimated $9 sold.
North Star Investment Management first reported a position in PPBT in Q3 2020 and held it in 21 quarters. The position peaked at $1K in Q3 2022. 19 funds tracked by Wall St. Rank hold PPBT as of Q4 2025.
- North Star Investment Management reported no remaining Purple Biotech position as of Q4 2025 after selling out during the quarter.
- North Star Investment Management sold 2 Purple Biotech shares in Q4 2025, an estimated $9.
- North Star Investment Management first reported a position in Purple Biotech in Q3 2020 and held it in 21 quarters.
- North Star Investment Management's Purple Biotech position peaked at $1K in Q3 2022.
- 19 funds tracked by Wall St. Rank held Purple Biotech as of Q4 2025.
Based on North Star Investment Management's 13F filing for Q4 2025, filed 30 Jan 2026.